MYUNGMOON Pharm co.,Ltd (KOSE: A017180)
Health Care · Pharmaceuticals · KR
₩1,286.00
+1.02% today · -25.8% 1Y
MYUNGMOON Pharm co.,Ltd (KOSE: A017180) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $31.98M.
Over the last twelve months the share price has lost 25.8%, trading between 1.00K and 2.06K.
Tweenvest scores MYUNGMOON Pharm co.,Ltd across four factors: quality 55/100, value 63/100. Its strongest factor is value.
A017180 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.98M
- Revenue (TTM)
- $129.03M
- P/E
- —
- EPS
- -49.77
- Dividend yield
- —
- Beta (5Y)
- 0.29
- 52-week high
- ₩2,055.00
- 52-week low
- ₩1,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 33.43M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Medical Developments International LimitedASX: MVP | $32.63M | AU$0.42 | -2.35% |
| Regent Pacific Group LimitedSEHK: 575 | $32.54M | HK$0.88 | +3.55% |
| PRISM BioLab Co.,LTDTSE: 206A | $32.45M | ¥139.00 | -4.79% |
| SoftOx Solutions ASOB: SOFTX | $32.42M | Nkr0.12 | -1.85% |
| Ambalal Sarabhai Enterprises LimitedBSE: 500009 | $31.90M | Rs40.29 | +6.25% |
| MIRA Pharmaceuticals, Inc.NasdaqCM: MIRA | $31.33M | $0.70 | -6.60% |
| BioNxt Solutions Inc.CNSX: BNXT | $31.00M | CA$0.33 | -14.47% |
| Sharp Therapeutics Corp.TSXV: SHRX | $30.85M | CA$— | — |
Figures last refreshed Oct 11, 2026.